Scientists have found a way to predict the aggressiveness of common cancers.
They’ve developed a tool that can forecast the outcome of common cancer types like breast cancer and help identify whether patients need early treatment.
The work is based on analysing the length of telomeres – caps found at the ends of chromosomes that protect the genetic information from damage.
Cardiff University spin-out TeloNostiX worked with Cardiff and Vale University Health Board to develop the technology.
Professor Duncan Baird, Chief Technology Officer, TeloNostiX said: “Our tests provide precise prognostic information that will allow cancer patients and their doctors to make informed clinical decisions about their disease.”
The collaboration will pick up a Medical Innovation prize at Cardiff University’s Innovation and Impact Awards later this month.
Full story and short film: https://www.cardiff.ac.uk/news/view/1195011-innovation-award-for-diagnostic-cancer-technology
**Please note, Thumbay Group, Gulf Medical University, and HEALTH magazine are not liable nor responsible for the facts, figures, and overall content of the press releases on our portal.
